title: Expansion of the global measles and rubella laboratory network 2005-09.
abstract: Enhancing measles surveillance with integration of epidemiologic and laboratory information is one of the key strategies for accelerated measles control and elimination. The World Health Organization (WHO) Global Measles and Rubella Laboratory Network (LabNet) has been developed since 2000 to currently include 690 laboratories serving 183 countries. The LabNet testing strategy follows well-validated, standardized procedures for confirming suspected cases and for monitoring measles and rubella virus transmission patterns. The strength of the LabNet is a strong quality assurance program that monitors the performance of all laboratories through annual proficiency testing and continuous assessment. In the 5-year period 2005-2009, the results of >1 million measles immunoglobulin M (IgM) tests have been reported by the LabNet and, in addition, sequence information on >7000 measles and 600 rubella viruses has been shared. Progress with the development of the LabNet during 2005-2009 is discussed.
authors.affiliation: Department of Immunization, Vaccines and Biologicals, Family and Community Health Cluster, World Health Organization (WHO), Geneva, Switzerland. featherstoned@who.int
authors.forename: David A
authors.initials: DA
authors.lastname: Featherstone
authors.forename: Paul A
authors.initials: PA
authors.lastname: Rota
authors.forename: Joseph
authors.initials: J
authors.lastname: Icenogle
authors.forename: Mick N
authors.initials: MN
authors.lastname: Mulders
authors.forename: Youngmee
authors.initials: Y
authors.lastname: Jee
authors.forename: Hinda
authors.initials: H
authors.lastname: Ahmed
authors.forename: Ana Maria Bispo
authors.initials: AM
authors.lastname: de Filippis
authors.forename: Nalini
authors.initials: N
authors.lastname: Ramamurty
authors.forename: Eugene
authors.initials: E
authors.lastname: Gavrilin
authors.forename: Charles
authors.initials: C
authors.lastname: Byabamazima
authors.forename: Annick
authors.initials: A
authors.lastname: Dosseh
authors.forename: Wenbo
authors.initials: W
authors.lastname: Xu
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Komase
authors.forename: Masato
authors.initials: M
authors.lastname: Tashiro
authors.forename: David
authors.initials: D
authors.lastname: Brown
authors.forename: William J
authors.initials: WJ
authors.lastname: Bellini
authors.forename: Peter
authors.initials: P
authors.lastname: Strebel
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D014943:Global Health; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007391:International Cooperation; D007753:Laboratories / Q000458:organization & administration* / Q000592:standards; D008457:Measles / Q000175:diagnosis* / Q000453:epidemiology*; D008459:Measles virus / Q000302:isolation & purification; D011159:Population Surveillance; D011785:Quality Assurance, Health Care; D012409:Rubella / Q000175:diagnosis* / Q000453:epidemiology*; D012412:Rubella virus / Q000302:isolation & purification; D013997:Time Factors
chemical_list: D000914:Antibodies, Viral; D007075:Immunoglobulin M